Recent Updates
Recently added Catalysts
CYAN

Corporation: Investors and Media: Cyanotech Corporation Russell Communications Group Jeffrey H. Sakamoto Bruce Russell (808) 326 1353 (310) 559 4955 x101 jsakamoto@cyanotech.com brucerusse

Key Takeaway: Contacts: Corporation: Investors and Media: Cyanotech Corporation Russell Communications Group Jeffrey H. Sakamoto Bruce Russell (808) 326 1353 (310) 559 4955 x101 jsakamoto@cyanotech.com brucerussell@ruscom.com Cyanotech Corporation Reports First Quarter Fiscal 2

Full Press Release Details

Contacts: Corporation: Investors and Media:
Cyanotech Corporation Russell Communications Group
Jeffrey H. Sakamoto Bruce Russell
(808) 326 1353 (310) 559 4955 x101
jsakamoto@cyanotech.com brucerussell@ruscom.com
Cyanotech Corporation Reports
First Quarter Fiscal 2006 Financial Results
Reports Net Income of $153,000 on Sales of $3,029,000
KONA, Hawaii August 11, 2005 Cyanotech Corporation (Nasdaq SmallCap:
CYAN News), a world leader in producing high-value natural products from
microalgae, today announced results for the first fiscal quarter, ended June 30,
the three months ended June 30, 2005 the Company reported net sales of
$3,029,000, an increase of $322,000 or 12%, compared to sales of $2,707,000
reported for the comparable period of the prior fiscal year. Gross profit for the first quarter of fiscal
2006 was $1,025,000, an increase of 16% from gross profit of $887,000 for the
same period last year. The Company
reported gross profit margin of 34% for the current year quarter, a slight
increase from gross profit of 33% reported for the first quarter of the prior
expenses for the first quarter of fiscal 2006 were $817,000, an increase of 13%
from the $726,000 reported for the comparable period of the prior fiscal year, General
and Administrative and Sales and Marketing expense both increased; these
increases were partially offset by decreases in research and development
expense. Income from operations amounted
to $208,000, a 29% increase from income from operations of $161,000 reported
for the comparable quarter of the prior year.
Other expense, net for the first quarter of fiscal 2006 was $50,000, an
increase of 52% from other expense, net of $33,000 reported for the comparable
quarter of the prior fiscal year. The
Company reported net income of $153,000, or $0.01 per diluted share, an
increase from net income of $113,000, or $0.01 per diluted share, for the
comparable quarter of the prior fiscal year.
first quarter of fiscal 2006 was characterized by stronger sales of all of our
products compared to the first quarter of fiscal 2005 and the prior consecutive
quarter, said Gerald R. Cysewski, Ph.D., Chairman, President and Chief
Executive Officer. We have been cultivating
Spirulina Pacifica for 20 years at our Kona facility and our focus on quality,
product safety and high value has attracted customers who desire this high
quality product. In turn, this
translates into high demand for our Spirulina products. Our BioAstin anti-inflammatory antioxidant has
the same reputation for quality, safety and high value and as it is a
relatively new product, we are excited about its potential for increased sales. Contributing to our results for this quarter
were increased sales of NatuRose natural astaxanthin to the Japan aquaculture
market. We remain cautious about the
recovery rate of that market following the disruption caused by a severe
typhoon season a year ago. With the
completion of our production facility upgrade last fiscal year we are now able
to better adapt our cultivation and processing according to market trends. Our results may vary from quarter to quarter,
but our goal is to achieve annual revenue growth and increase profitability.
73-4460 Queen Kaahumanu
Highway, #102 - Kailua-Kona, Hawaii 96740
(808) 326-1353 fax (808) 329-3597 - www.cyanotech.com
Corporation, a world leader in microalgal technology, produces BioAstin
natural astaxanthin and Spirulina Pacifica all-natural, functional nutrients
that enhance human health and nutrition, providing significant antioxidant,
anti-inflammatory and immune response benefits.
The Company s other compounds, such as NatuRose natural astaxanthin,
promote animal nutrition and health, primarily in aquaculture. Cyanotech extracts these compounds from
microalgae grown at its 90-acre facility in Hawaii using proprietary
processes, and distributes them to nutraceutical, nutritional supplement,
cosmeceutical and aquaculture feed makers and marketers worldwide. Corporate
data and product information are available at www.cyanotech.com
Harbor Statement under the Private Securities Litigation Reform Act of 1995
for statements of historical fact, the statements in this press release are
forward-looking. Such statements are
subject to a number of risks and uncertainties that could cause actual results
to differ materially from the statements made.
These factors include, but are not limited to, general economic
conditions, forecasts of sales in future periods, changes in sales levels to
our largest customers, weather patterns, production problems caused by
contamination, risks associated with the acceptance of new products,
competition, foreign exchange fluctuations, government regulation, and other
factors more fully detailed in the Company s recent Form 10-Q and
annual form 10-K filings with the Securities and Exchange Commission.
Corporation will hold a conference call on Thursday, August 11, 2005 at
5:30 p.m. Eastern Time to be broadcast live over the Internet. It can be accessed by all interested parties
by linking through the Investor Broadcast Network s VCall website at
www.vcall.com or through Cyanotech s website, http://www.cyanotech.com. To access the simultaneous webcast on the
Cyanotech site, select the Recent News section from Cyanotech s home
page. Click on the announcement
entitled, Cyanotech Announces Fiscal Year 2006 First Quarter Financial Results
Webcast August 11, 2005. To listen
to the live call, please go to either website at least 15 minutes prior to the
start of the call to register, download, and install any necessary audio
software. For those who are not able to
listen to the live broadcast, a replay will be available shortly after the call
and will be archived for a period of one calendar year.
CYANOTECH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(In thousands, except per share amounts)
Three Months Ended June 30,
2005 2004
NET SALES $ 3,029 $ 2,707
COST OF PRODUCT SALES 2,004 1,820
Gross Profit 1,025 887
OPERATING EXPENSES:
Research and development 46 65
General and administrative 438 367
Sales and marketing 333 294
Total operating expenses 817 726
Income from operations 208 161
OTHER INCOME (EXPENSE):
Interest income 15 8
Interest expense (55 ) (39 )
Other expense, net (10 ) (2 )
Total other expense, net (50 ) (33 )
Income (loss) before income taxes 158 128
INCOME TAX EXPENSE 5 15
NET INCOME $ 153 $ 113
NET INCOME PER SHARE:
Basic $ 0.01 $ 0.01
Diluted $ 0.01 $ 0.01
SHARES USED IN CALCULATION OF NET INCOME PER SHARE:
Basic 20,896 20,736
Diluted 21,019 20,992
COMPREHENSIVE INCOME :
Net income $ 153 $ 113
Other comprehensive income (loss) (2 ) 14
$ 151 $ 127
thousands except per share amounts)
June 30, March 31,
2005 2005
ASSETS
Current assets:
Cash and cash equivalents $ 1,743 $ 2,005
Short-term investments 1,000 1,000
Accounts receivable, net 2,371 2,069
Refundable income taxes 51 97
Inventories 1,589 1,565
Prepaid expenses and other 168 85
Total current assets 6,922 6,821
Equipment and leasehold improvements, net 10,877 11,174
Other assets 541 547
Total assets $ 18,340 $ 18,542
LIABILITIES AND STOCKHOLDERS EQUITY
Current liabilities:
Current maturities of long-term debt $ 354 $ 355
Accounts payable 576 977
Accrued expenses 521 387
Total current liabilities 1,451 1,719
Long-term debt, excluding current maturities 1,658 1,743
Total liabilities 3,109 3,462
Stockholders equity:
Common stock of $0.005 par value, shares authorized 30,000,000; 20,896,265 shares issued and outstanding at June 30, 2005 and March 31, 2005 104 104
Additional paid-in capital 27,298 27,298
Accumulated other comprehensive income - foreign currency translation adjustments 25 27
Accumulated deficit (12,196 ) (12,349 )
Total stockholders equity 15,231 15,080
Total liabilities and stockholders equity $ 18,340 $ 18,542
Last updated: Aug 11, 2005